Advertisement
Policy Platform

Policy Platform The Policy Platform is for authors to discuss policies that could improve the lives of those at risk of, or affected by, the NTDs.

See all article types »

New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients

  • Isabela Ribeiro,

    Affiliation: Drugs for Neglected Diseases initiative, Geneva, Switzerland

    X
  • Ann-Marie Sevcsik,

    Affiliation: Drugs for Neglected Diseases initiative, Geneva, Switzerland

    X
  • Fabiana Alves,

    Affiliation: Drugs for Neglected Diseases initiative, Geneva, Switzerland

    X
  • Graciela Diap,

    Affiliation: Drugs for Neglected Diseases initiative, Geneva, Switzerland

    X
  • Robert Don,

    Affiliation: Drugs for Neglected Diseases initiative, Geneva, Switzerland

    X
  • Michael O. Harhay,

    Affiliation: Masters of Public Health Program, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America

    X
  • Shing Chang,

    Affiliation: Drugs for Neglected Diseases initiative, Geneva, Switzerland

    X
  • Bernard Pecoul mail

    bpecoul@dndi.org

    Affiliation: Drugs for Neglected Diseases initiative, Geneva, Switzerland

    X
  • Published: July 07, 2009
  • DOI: 10.1371/journal.pntd.0000484

About the Authors

Isabela Ribeiro, Ann-Marie Sevcsik, Fabiana Alves, Graciela Diap, Robert Don, Shing Chang, Bernard Pecoul
Drugs for Neglected Diseases initiative, Geneva, Switzerland
Michael O. Harhay
Masters of Public Health Program, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America

Corresponding Author

Email: bpecoul@dndi.org

Competing Interests

The authors have declared that no competing interests exist.